0,960  0,002  CYP2C9 substrate
0,955  0,002  CYP2C19 substrate
0,951  0,003  Transcription factor NF kappa B inhibitor
0,945  0,003  CYP2D6 substrate
0,934  0,002  UGT1A6 substrate
0,910  0,005  Apoptosis agonist
0,892  0,004  CYP3A4 substrate
0,891  0,004  Teratogen
0,881  0,005  Embryotoxic
0,856  0,004  Chemopreventive
0,850  0,004  Cardiotonic
0,824  0,002  Anesthetic general
0,825  0,006  Antineoplastic (lung cancer)
0,806  0,003  Proliferative diseases treatment
0,810  0,008  Antineoplastic (breast cancer)
0,804  0,003  Antineoplastic (sarcoma)
0,798  0,005  CYP1A2 substrate
0,780  0,005  Antineoplastic (ovarian cancer)
0,778  0,003  UGT1A1 substrate
0,779  0,009  Antineoplastic (colorectal cancer)
0,767  0,004  Cytotoxic
0,759  0,004  Antineoplastic (brain cancer)
0,753  0,004  Antineoplastic (pancreatic cancer)
0,752  0,004  Antiparasitic
0,743  0,003  Antihelmintic
0,737  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,732  0,007  Prostate cancer treatment
0,725  0,005  Immunosuppressant
0,731  0,011  Antineoplastic (colon cancer)
0,736  0,024  Antiinflammatory
0,703  0,008  Cholesterol antagonist
0,695  0,005  Antineoplastic (glioma)
0,683  0,002  ATPase inhibitor
0,679  0,007  NOS2 expression inhibitor
0,678  0,012  Respiratory analeptic
0,676  0,011  Antibacterial
0,672  0,016  Antileukemic
0,661  0,007  Antineoplastic (non-small cell lung cancer)
0,658  0,005  UDP-glucuronosyltransferase substrate
0,655  0,014  Carcinogenic
0,637  0,000  Na+ K+ transporting ATPase inhibitor
0,630  0,007  DNA damaging
0,620  0,012  Analeptic
0,617  0,012  Antineoplastic (cervical cancer)
0,608  0,005  Antineoplastic enhancer
0,605  0,005  Antineoplastic (glioblastoma multiforme)
0,604  0,013  Antineoplastic (melanoma)
0,592  0,005  Diuretic
0,576  0,005  Antineoplastic (liver cancer)
0,579  0,016  Sensitization
0,586  0,027  TNF expression inhibitor
0,570  0,012  Caspase 3 stimulant
0,567  0,012  Nitric oxide antagonist
0,566  0,011  Antifungal
0,561  0,007  Heart failure treatment
0,545  0,008  Antineoplastic (lymphoma)
0,547  0,015  NOS3 expression inhibitor
0,535  0,014  Antineoplastic (multiple myeloma)
0,554  0,034  Antineoplastic (solid tumors)
0,515  0,009  Antineoplastic (renal cancer)
0,519  0,019  Hepatic disorders treatment
0,493  0,004  Antineoplastic antibiotic
0,505  0,022  Cardioprotectant
0,503  0,020  Cytostatic
0,475  0,007  Interferon gamma antagonist
0,474  0,029  Antihypercholesterolemic
0,475  0,032  Immunostimulant
0,458  0,021  ICAM1 expression inhibitor
0,440  0,005  Interleukin 6 antagonist
0,437  0,005  Antidiarrheal
0,444  0,025  Mutagenic
0,439  0,028  Antioxidant
0,420  0,010  Melanin inhibitor
0,421  0,018  Antineoplastic (endocrine cancer)
0,471  0,072  Caspase 9 stimulant
0,409  0,010  Antineoplastic (squamous cell carcinoma)
0,411  0,014  Sodium/bile acid cotransporter inhibitor
0,398  0,011  UGT2B7 substrate
0,396  0,019  Transcription factor STAT3 inhibitor
0,421  0,044  Antithrombotic
0,399  0,031  UGT2B4 substrate
0,369  0,006  Cholesterol synthesis inhibitor
0,395  0,040  Apoptosis antagonist
0,373  0,019  P-glycoprotein inhibitor
0,394  0,041  AR expression inhibitor
0,357  0,006  Antifungal enhancer
0,366  0,017  Contraceptive
0,359  0,013  Topoisomerase II inhibitor
0,362  0,017  Hepatoprotectant
0,362  0,018  Antiviral (Herpes)
0,365  0,029  Angiogenesis stimulant
0,344  0,016  Anesthetic
0,337  0,015  Lipocortins synthesis antagonist
0,362  0,043  UGT1A9 substrate
0,332  0,015  Peptidyltransferase inhibitor
0,337  0,021  Antiviral (Influenza)
0,332  0,026  RNA-directed DNA polymerase inhibitor
0,322  0,017  Prostate disorders treatment
0,320  0,017  Acaricide
0,347  0,045  Chemoprotective
0,339  0,038  Transcription factor STAT inhibitor
0,342  0,042  Antipyretic
0,297  0,003  Toll-Like receptor 4 antagonist
0,296  0,003  Antirickettsial
0,336  0,046  Antineoplastic (osteosarcoma)
0,303  0,013  Antiviral (Hepatitis B)
0,299  0,011  Topoisomerase I inhibitor
0,298  0,022  Antiacne
0,294  0,023  Antineoplastic (carcinoma)
0,273  0,003  Glycine receptor agonist
0,283  0,019  Antiviral (Influenza A)
0,321  0,060  Interleukin 2 agonist
0,271  0,013  Aldose reductase substrate
0,271  0,014  Psychosexual dysfunction treatment
0,300  0,044  DNA synthesis inhibitor
0,272  0,018  Acute respiratory distress syndrome (ARDS) treatment
0,261  0,015  DNA intercalator
0,293  0,054  Free radical scavenger
0,337  0,098  Antipruritic, allergic
0,242  0,014  Antihemorrhagic
0,232  0,004  Protein 50S ribosomal subunit inhibitor
0,303  0,075  Antineoplastic (small cell lung cancer)
0,290  0,067  Antihypoxic
0,250  0,027  Protein kinase stimulant
0,235  0,013  Microtubule formation inhibitor
0,245  0,027  Skin whitener
0,272  0,055  Antineoplastic (lymphocytic leukemia)
0,222  0,010  Growth stimulant
0,273  0,064  Hypoglycemic
0,218  0,009  Antineoplastic alkaloid
0,291  0,083  Antimycobacterial
0,215  0,011  Antibiotic
0,234  0,041  Antipruritic, non-allergic
0,203  0,014  Topoisomerase II alpha inhibitor
0,257  0,072  Tumour necrosis factor alpha release inhibitor
0,205  0,025  Alkylator
0,199  0,019  Cyclooxygenase 3 inhibitor
0,217  0,043  Antihelmintic (Nematodes)
0,186  0,020  Choleretic
0,230  0,066  Antihypertriglyceridemic
0,186  0,024  Expectorant
0,170  0,012  Antiviral (Trachoma)
0,182  0,028  Antifungal (Cryptococcus)
0,191  0,044  UGT2B9 substrate
0,192  0,046  UGT2B15 substrate
0,152  0,007  ATPase (Vacuolar H+) inhibitor
0,210  0,067  Neurotrophic factor enhancer
0,226  0,085  Antiprotozoal (Leishmania)
0,164  0,024  Antineoplastic, alkylator
0,187  0,047  Lipid peroxidase inhibitor
0,151  0,018  Selectin antagonist
0,140  0,010  Bile acid receptor antagonist
0,188  0,061  Prostatic (benign) hyperplasia treatment
0,162  0,041  Farnesoid X receptor antagonist
0,122  0,006  Antitreponemal
0,129  0,014  Glycine receptor antagonist
0,146  0,031  AMP-activated protein kinase stimulant
0,122  0,007  Antimycoplasmal
0,122  0,012  Prokinetic
0,131  0,021  Transcription factor NF kappa B stimulant
0,136  0,027  Anabolic
0,128  0,019  Contraceptive male
0,175  0,070  Antineoplastic (bone cancer)
0,181  0,082  Platelet adhesion inhibitor
0,127  0,036  Interleukin 2 antagonist
0,224  0,133  Bone diseases treatment
0,163  0,073  UGT1A3 substrate
0,145  0,057  Ca2+-transporting ATPase inhibitor
0,087  0,007  RNA-directed RNA polymerase stimulant
0,203  0,124  Antiosteoporotic
0,157  0,081  Arachidonic acid antagonist
0,165  0,094  Antiviral (Hepatitis)
0,103  0,032  Antiprotozoal activity enhancer
0,115  0,048  Dementia treatment
0,095  0,029  T cell inhibitor
0,111  0,046  Vascular dementia treatment
0,133  0,073  Amylase inhibitor
0,081  0,023  Estrogen agonist
0,127  0,069  Antineoplastic (uterine cancer)
0,152  0,096  UGT2B10 substrate
0,072  0,019  Lipocortins synthesis agonist
0,071  0,019  Antibiotic Glycopeptide-like
0,060  0,009  Antibiotic Aminoglycoside-like
0,186  0,135  Lipoprotein disorders treatment
0,074  0,026  Hypercalcemia treatment
0,115  0,072  DNA polymerase I inhibitor
0,046  0,004  GRP78 expression inhibitor
0,045  0,006  Motilin receptor agonist
0,099  0,060  UGT2B11 substrate
0,050  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,069  0,032  Androgen agonist
0,203  0,166  Angiogenesis inhibitor
0,055  0,021  Microtubule stabilization
0,064  0,029  Peristaltic stimulant
0,042  0,010  Protein 30S ribosomal subunit inhibitor
0,062  0,031  Postmenopausal disorders treatment
0,108  0,077  Adenylate cyclase inhibitor
0,167  0,137  VCAM1 expression inhibitor
0,148  0,118  Toxic, respiratory center
0,107  0,080  Estrogen antagonist
0,031  0,004  Antibiotic Macrolide-like
0,095  0,069  Chronic obstructive bronchitis treatment
0,142  0,117  Wound healing agent
0,145  0,121  Antiarrhythmic
0,058  0,035  Acetyl-CoA transferase 2 inhibitor
0,082  0,059  Antispirochetal
0,096  0,077  UGT2B1 substrate
0,042  0,027  Hypogonadism treatment
0,041  0,028  Cholesterol absorption inhibitor
0,114  0,105  Neurotrophic factor
0,120  0,111  UGT1A4 substrate
0,018  0,011  Telomerase stimulant
0,033  0,027  Tubulin agonist
0,123  0,119  Pregnane X receptor agonist
0,157  0,155  Vascular (periferal) disease treatment

